Novo Nordisk's diabetes pill Rybelsus slashes cardiovascular risk
Featured

Novo Nordisk’s diabetes pill Rybelsus slashes cardiovascular risk

Novo Nordisk on Saturday said its diabetes pill Rybelsus showed cardiovascular benefits in a late-stage trial, paving the way for […]